Business
ACADIA Pharmaceuticals Appoints Stephanie Fagan as Senior Vice President, Corporate Affairs and Chief Communications Officer
SAN DIEGO--(BUSINESS WIRE)-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Stephanie Fagan has been appointed to the newly created position
About this update from Acadia Pharmaceuticals Inc.
[{"type":"text","content":" SAN DIEGO--(BUSINESS WIRE)--\nACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Stephanie Fagan has been appointed to the newly created position of Senior Vice President, Corporate Affairs and Chief Communications Officer. Ms. Fagan will be responsible for all corporate communications and serve as a member of the company’s Executive Management Committee. She will report to Elena Ridloff, CFA, Executive Vice President, Chief Financial Officer of ACADIA.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191218005733/en/Stephanie Fagan, Senior Vice President, Corporate Affairs and Chief Communications Officer (Photo: Business Wire)\n\n“Stephanie brings extensive experience working with leading healthcare companies and brands, and her commitment to patients, customer and community engagement will strengthen the ACADIA mission of improving the lives of people who struggle with unmet needs in neurological disorders,” said Ms. Ridloff. “I’m delighted to welcome Stephanie to ACADIA as her strong track record of developing the communications function with high-performing teams that engage multiple stakeholders will advance our business strategies.”\n\n\n“As ACADIA continues to expand its research, development and commercial efforts, I look forward to working with the team and engaging with the communities we serve to keep ACADIA at the forefront of developing and delivering new therapies for patients and their families with central nervous system disorders,” said Ms. Fagan.\n\n\nMs. Fagan joins ACADIA from bluebird bio, Inc. where she was Senior Vice President, Corporate Communications and built the first communications function as the company transitioned from a clinical stage to commercial stage company. Prior to bluebird, Ms. Fagan led the corporate affairs functions at Alexion, Shire, and West Health and has experience overseeing corporate, financial, product, and internal communications, as well as corporate social responsibility, patient advocacy, and government affairs. Over the course of her career, Ms. Fagan has served in positions of increasing influence and impact in the healthcare industry, including roles at Johnson & Johnson, Allergan, Pharmacia, Inc. (now Pfizer), and Boston Scientific Corporation.\n\n\nMs. Fagan earned a Master’s degree in Communic...